WuXi Biologics Launches First Commercial Drug Product Facility for Pre-Filled Syringes
yahoo.com
finance
2022-06-06 00:30:00

WuXi Biologics offers global partners high-efficiency and high-quality manufacturing services for clinical trial and commercial supply by increasing pre-filled syringes (PFS) capacity to 17 million units per year.

WuXi Biologics has established a global manufacturing network with 9 drug product facilities for vial and PFS in China and Germany, and is now one of the global leaders in drug product CDMO services.

Advanced single-use technology and automated equipment allow for decreasing risk of contamination.
